Business Context and Reporting Period
This Form 8-K is a current report filed by Integrity Applications, Inc. (not Glucotrack, Inc.) on March 6, 2013, covering events that occurred on February 24, 2013. The company is incorporated in Delaware and operates from Ashkelon, Israel.
Key Financial Metrics
The filing does not provide specific values for revenue, profit, cash flow, margins, or total debt. However, it references a liquidity condition for executive compensation: cash bonuses are contingent upon the company's wholly owned subsidiary, A.D. Integrity Applications, Ltd., maintaining working capital of at least $2,000,000 on the payment date.
Material Changes
- Board Expansion: The Board of Directors increased its size from five to six members.
- New Director: Israel Ehrlich was appointed to fill the newly created vacancy.
- Executive Compensation: The Board approved cash bonus awards for the CEO and Executive Vice President of Operations, totaling up to $90,000 combined.
Guidance, Outlook, and Risks
The filing outlines specific performance milestones tied to the company's CE Mark application process. The approved bonuses are payable in two installments (40% and 60%) contingent upon:
- Submission of the technical file to the notified body.
- Submission of clinical data to the notified body.
Contingency: Payment of these bonuses is strictly conditional on the subsidiary having working capital of at least $2,000,000 on the date of each installment. The filing states there are no undisclosed arrangements regarding the new director's appointment.
Investor Verification Checklist
- Verify the current working capital status of A.D. Integrity Applications, Ltd. to assess the likelihood of bonus payments.
- Confirm the status of the CE Mark application, specifically the submission of technical files and clinical data.
- Review the background and qualifications of the newly appointed director, Israel Ehrlich.
- Check subsequent filings for confirmation of whether the bonus installments were actually paid.